Literature DB >> 29207763

Carbamazepine Induced Thrombocytopenia.

Ruhi Kumar1, Sridhar Chivukula2, Goutham Reddy Katukuri2, U K Chandrasekhar3, K N Shivashankar4.   

Abstract

Antiepileptic Drugs (AEDs) are commonly associated with haematological disorders, including anaemia, thrombocytopenia, neutropenia and even bone marrow failure. Fatal disorders like aplastic anaemia are uncommon. On exploring through the literature, older AEDs are more associated with haematological alterations than newer AEDs, and careful monitoring is warranted especially with phenytoin, carbamazepine and valproate. The exact cause of these alterations is not established, though immune mechanisms and pharmacology of individual drugs are the proposed mechanisms, a further research along this path is underway. Of worth mentioning here, this predilection of older AEDs towards haematological disorders is pronounced in children compared to adults. We present here a case of congenital heart disease with history of brain abscess and seizures, on carbamazepine who presented to our hospital with toothache. Routine screening prior to tooth extraction revealed thrombocytopenia. Further evaluation revealed the association of carbamazepine and thrombocytopenia, which mandated discontinuation of drug and switching patient to alternative AED.

Entities:  

Keywords:  Antiepileptic drugs; Cyanotic congenital heart disease; Haematological alterations

Year:  2017        PMID: 29207763      PMCID: PMC5713785          DOI: 10.7860/JCDR/2017/26271.10659

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  2 in total

Review 1.  Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management.

Authors:  R H Aster; B R Curtis; J G McFarland; D W Bougie
Journal:  J Thromb Haemost       Date:  2009-04-02       Impact factor: 5.824

Review 2.  A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia.

Authors:  D M Arnold; S Kukaswadia; I Nazi; A Esmail; L Dewar; J W Smith; T E Warkentin; J G Kelton
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.